MINAPHARM Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 2/6
MINAPHARM Pharmaceuticals has a total shareholder equity of EGP4.4B and total debt of EGP5.1B, which brings its debt-to-equity ratio to 114.1%. Its total assets and total liabilities are EGP11.8B and EGP7.4B respectively. MINAPHARM Pharmaceuticals's EBIT is EGP349.4M making its interest coverage ratio 0.7. It has cash and short-term investments of EGP3.2B.
Key information
114.1%
Debt to equity ratio
ج.م5.07b
Debt
| Interest coverage ratio | 0.7x |
| Cash | ج.م3.20b |
| Equity | ج.م4.45b |
| Total liabilities | ج.م7.38b |
| Total assets | ج.م11.83b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MIPH's short term assets (EGP5.5B) exceed its short term liabilities (EGP4.7B).
Long Term Liabilities: MIPH's short term assets (EGP5.5B) exceed its long term liabilities (EGP2.6B).
Debt to Equity History and Analysis
Debt Level: MIPH's net debt to equity ratio (42.3%) is considered high.
Reducing Debt: MIPH's debt to equity ratio has increased from 79.2% to 114.1% over the past 5 years.
Debt Coverage: MIPH's debt is not well covered by operating cash flow (3.2%).
Interest Coverage: MIPH's interest payments on its debt are not well covered by EBIT (0.7x coverage).